Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biodesix (BDSX) Gains from Sales and Divestitures (2022 - 2025)

Biodesix's Gains from Sales and Divestitures history spans 4 years, with the latest figure at $37000.0 for Q4 2025.

  • For Q4 2025, Gains from Sales and Divestitures rose 23.33% year-over-year to $37000.0; the TTM value through Dec 2025 reached $37000.0, up 23.33%, while the annual FY2025 figure was $37000.0, 23.33% up from the prior year.
  • Gains from Sales and Divestitures reached $37000.0 in Q4 2025 per BDSX's latest filing, up from $4000.0 in the prior quarter.
  • In the past five years, Gains from Sales and Divestitures ranged from a high of $710000.0 in Q4 2023 to a low of $2000.0 in Q3 2024.
  • Average Gains from Sales and Divestitures over 4 years is $141266.7, with a median of $37000.0 recorded in 2025.
  • Peak YoY movement for Gains from Sales and Divestitures: surged 280.43% in 2023, then tumbled 98.48% in 2024.
  • A 4-year view of Gains from Sales and Divestitures shows it stood at $357000.0 in 2022, then surged by 98.88% to $710000.0 in 2023, then crashed by 95.77% to $30000.0 in 2024, then grew by 23.33% to $37000.0 in 2025.
  • Per Business Quant, the three most recent readings for BDSX's Gains from Sales and Divestitures are $37000.0 (Q4 2025), $4000.0 (Q3 2025), and $7000.0 (Q2 2025).